BuzzFeed (BZFD) Competitors

Oncology Institute (NASDAQ:TOI) and BuzzFeed (NASDAQ:BZFD) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, media sentiment, institutional ownership, community ranking and earnings.

Which has stronger earnings and valuation, TOI or BZFD?

Oncology Institute has higher revenue and earnings than BuzzFeed. BuzzFeed is trading at a lower price-to-earnings ratio than Oncology Institute, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oncology Institute	$324.24M	0.15	-$83.07M	-$0.92	-0.73
BuzzFeed	$252.68M	0.31	-$88.58M	-$2.46	-0.89

Does the media refer more to TOI or BZFD?

In the previous week, Oncology Institute had 11 more articles in the media than BuzzFeed. MarketBeat recorded 18 mentions for Oncology Institute and 7 mentions for BuzzFeed. Oncology Institute's average media sentiment score of 0.73 beat BuzzFeed's score of -0.45 indicating that BuzzFeed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Oncology Institute	1 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	5 Very Negative mention(s)	Neutral
BuzzFeed	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts rate TOI or BZFD?

Oncology Institute presently has a consensus target price of $2.25, suggesting a potential upside of 234.22%. Given BuzzFeed's higher probable upside, equities analysts plainly believe Oncology Institute is more favorable than BuzzFeed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oncology Institute	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
BuzzFeed	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Do insiders & institutionals believe in TOI or BZFD?

36.9% of Oncology Institute shares are held by institutional investors. Comparatively, 37.6% of BuzzFeed shares are held by institutional investors. 9.5% of Oncology Institute shares are held by insiders. Comparatively, 20.3% of BuzzFeed shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Is TOI or BZFD more profitable?

Oncology Institute has a net margin of -24.56% compared to Oncology Institute's net margin of -32.51%. Oncology Institute's return on equity of -52.57% beat BuzzFeed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oncology Institute	-24.56%	-80.46%	-28.14%
BuzzFeed	-32.51%	-52.57%	-14.96%

Does the MarketBeat Community prefer TOI or BZFD?

Oncology Institute received 2 more outperform votes than BuzzFeed when rated by MarketBeat users. Likewise, 66.67% of users gave Oncology Institute an outperform vote while only 11.11% of users gave BuzzFeed an outperform vote.

Company	Underperform	Outperform
Oncology Institute	Outperform Votes 4 66.67%	Underperform Votes 2 33.33%
BuzzFeed	Outperform Votes 2 11.11%	Underperform Votes 16 88.89%

Which has more risk and volatility, TOI or BZFD?

Oncology Institute has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500. Comparatively, BuzzFeed has a beta of 3.1, suggesting that its stock price is 210% more volatile than the S&P 500.

Summary

Oncology Institute beats BuzzFeed on 10 of the 17 factors compared between the two stocks.